Category          :  Antimalarial

Description     : Rimodar is a fixed-dose-combination of ultra-long acting sulphadoxine and pyrimethamine that is effective against falciparum malaria including chloroquine-resistant  falciparum malaria.

Composition    :  Each uncoated tablet contains:    

Sulphadoxine  USP	500      mg
Pyrimethamine  USP	25        mg

              

Indiations         :

*  Treatment of falciparum malaria including chloroquine- resistant malaria.

*  Presumptive treatment of falciparum malaria for the travelers in endemic

    areas.

Precautions     : Caution advised in mild to moderate renal or hepatic dysfunction, pregnancy, lactation, folate deficiency states and G6 PD deficiency.

Adverse effects :

Clinically reported adverse effects include cutaneous  eruptions, Stevens-Johnson syndrome, blood dyscrasias, anaphylactoid reactions, disseminated intravascular coagulation, urticaria, edema, arthralgia, nausea, vomiting, abdominal pain, diarrhea, headache, liver damage, neuritis, vertigo, tinnitus, ataxia, convulsions, toxic nephrosis and lupus erythematosus.

Presentation       : Strip of 10 x10, 50 x 3  and 1000’s  Jar

Dosage               :

Adults  :  3 Tablets given as a single dose

              4-6 yrs (11-20 kg)1tablet as a single dose 

              7-9 yrs (21-30 kg)  ½ tablet as a single dose

             10-14 yrs (31-45 kg) 2 tablets as a single dose                             

Shelf Life              : 36 months